NCT05210114Recruiting
Cutaneous Hydration Assessment in SCD
Cutaneous Hydration Assessment in Sickle Cell Disease
Source: ClinicalTrials.gov · Last updated 12 Nov 2025
Brief summary (registry, in English)
This study will validate the diagnostic accuracy of a cutaneous hydration sensor. This sensor will also be evaluated for its feasibility as a point-of-care device for the assessment of hydration status and its potential to guide hydration therapy in patients with sickle cell disease (SCD).
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 26 Dec 2021
- Start date
- 21 Jan 2022
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Enrico Novelli
- Diseases
- Sickle cell disease
- NCT number
- NCT05210114
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 21 Jan 2022 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participants being treated with experimental therapies in clinical trials
Age
- Participants under 12-years old
Who the study is looking for
- Diagnosis of Sickle Cell Disease (genotypes SS, SC, Sß-thalassemia, SD, SOArab)
- Participants must be ≥12-years old
- Participants that provide legally effective consent to all study procedures
Age in the registry: 12 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UPMC Sickle Cell Clinic Coordinator of this site? Confirm its status | Pittsburgh | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.